勘误：使用液相色谱-质谱联用技术和微线圈核磁共振技术对CB2激动剂AM9338进行代谢谱分析：鉴定一种新型二羟基金刚烷基代谢物。
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.
作者信息
Honrao Chandrashekhar, Ma Xiaoyu, Kulkarni Shashank, Joshi Vinit, Malamas Michael, Zvonok Alexander, Wood JodiAnne, Kautz Roger A, Strand David, Guo Jason J, Makriyannis Alexandros
机构信息
Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, United States.
MAK Scientific LLC, Burlington, MA, United States.
出版信息
Front Pharmacol. 2021 Apr 22;12:630274. doi: 10.3389/fphar.2021.630274. eCollection 2021.
Abstract
[This corrects the article DOI: 10.3389/fphar.2020.575691.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fphar.2020.575691。]
相似文献
1
Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.勘误：使用液相色谱-质谱联用技术和微线圈核磁共振技术对CB2激动剂AM9338进行代谢谱分析：鉴定一种新型二羟基金刚烷基代谢物。
Front Pharmacol. 2021 Apr 22;12:630274. doi: 10.3389/fphar.2021.630274. eCollection 2021.
2
Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.使用液相色谱-质谱联用和微线圈核磁共振对CB2激动剂AM9338进行代谢谱分析：鉴定一种新型二羟基金刚烷基代谢物。
Front Pharmacol. 2020 Sep 30;11:575691. doi: 10.3389/fphar.2020.575691. eCollection 2020.
3
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.N-金刚烷基取代的脲基可溶性环氧化物水解酶抑制剂的体外和体内代谢
Biochem Pharmacol. 2015 Dec 15;98(4):718-31. doi: 10.1016/j.bcp.2015.10.013. Epub 2015 Oct 19.
4
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.勘误：在MCF7阿霉素耐药细胞中发现新型阿霉素代谢物
Front Pharmacol. 2020 Nov 26;11:603491. doi: 10.3389/fphar.2020.603491. eCollection 2020.
5
Corrigendum: Interactions Between and : From Stereoselectivity to Deamination as a Metabolic Detoxification Mechanism of Amygdalin.勘误：[物质名称]与[物质名称]之间的相互作用：从立体选择性到脱氨作用作为苦杏仁苷的一种代谢解毒机制。
Front Pharmacol. 2022 Jan 5;12:831921. doi: 10.3389/fphar.2021.831921. eCollection 2021.
6
Statistically correlating NMR spectra and LC-MS data to facilitate the identification of individual metabolites in metabolomics mixtures.对 NMR 谱和 LC-MS 数据进行统计学关联，以促进代谢组学混合物中单个代谢物的鉴定。
Anal Bioanal Chem. 2019 Mar;411(7):1301-1309. doi: 10.1007/s00216-019-01600-z. Epub 2019 Feb 21.
7
Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.（3',5'-二氯-2,6-二羟基-联苯-4-基）-芳基/烷基-甲酮选择性CB2反向激动剂的合成与生物学评价
Bioorg Med Chem. 2015 Sep 1;23(17):5390-401. doi: 10.1016/j.bmc.2015.07.057. Epub 2015 Jul 29.
8
Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines.勘误：2,4,6-三取代-1,3,5-三嗪引发的大麻素受体2信号偏向性
Front Pharmacol. 2019 Apr 5;10:418. doi: 10.3389/fphar.2019.00418. eCollection 2019.
9
Corrigendum: Cinical, Metabolic, and Genetic Analysis and Follow-Up of Eight Patients With Mutations Presenting With Leigh/Leigh-Like Syndrome.勘误：8例患有 Leigh/Leigh样综合征相关突变患者的临床、代谢及基因分析与随访
Front Pharmacol. 2021 Jun 10;12:686933. doi: 10.3389/fphar.2021.686933. eCollection 2021.
10
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS.通过液相色谱-四极杆-飞行时间质谱联用仪（LC-Qq-TOF-MS）和液相色谱-固相萃取-低温核磁共振/质谱联用仪（LC-SPE-cryo-NMR/MS）对4-吡啶基咪唑型p38丝裂原活化蛋白激酶抑制剂ML3403进行体外代谢物鉴定
Xenobiotica. 2007 Mar;37(3):280-97. doi: 10.1080/00498250601089154.
Zotero 插件